DPEP1 expression promotes proliferation and survival of leukaemia cells and correlates with relapse in adults with common B cell acute lymphoblastic leukaemia

Jia-Min Zhang,Yan Xu,Robert P. Gale,Li-Xin Wu,Jing Zhang,Yong-Huai Feng,Ya-Zhen Qin,Hao Jiang,Qian Jiang,Bin Jiang,Yan-Rong Liu,Yu-Hong Chen,Yu Wang,Xiao-Hui Zhang,Lan-Ping Xu,Xiao-Jun Huang,Kai-Yan Liu,Guo-Rui Ruan
DOI: https://doi.org/10.1111/bjh.16505
2020-01-01
British Journal of Haematology
Abstract:Dehydropeptidase-1 (DPEP1) is a zinc-dependent metalloproteinase abnormally expressed in many cancers. However, its potential role in adults with B cell acute lymphoblastic leukaemia (ALL) is unknown. We found that in adults with common B cell ALL high DPEP1, transcript levels at diagnosis were independently associated with an increased cumulative incidence of relapse (CIR) and worse relapse-free survival (RFS) compared with subjects with low transcript levels. We show an increased proliferation and prosurvival role of DPEP1 in B cell ALL cells via regulation of phosphCREB and p53, which may be the biological basis of the clinical correlation we report. Our data implicate DPEP1 expression in the biology of common B cell ALL in adults. We report clinical correlates and provide a potential biological basis for these correlations. If confirmed, analysing DPEP1 transcript levels at diagnosis could help predict therapy outcomes. Moreover, regulation of DPEP1 expression could be a therapy target in B cell ALL.
What problem does this paper attempt to address?